Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Wolf

Showing results (51-60 of 219) with videos related to

Pageof 22
Sort By:
Journal of Virology|January 1, 1991
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell cultureH Schuitemaker, N A Kootstra, R E de Goede, et al.
The Laryngoscope|November 9, 2018
Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatomaCatharine A Hellingman, Simon Geerse, Maarten J F de Wolf, et al.
The Laryngoscope|February 24, 2011
Better performance with bone-anchored hearing aid than acoustic devices in patients with severe air-bone gapMaarten J F de Wolf, Sander Hendrix, Cor W R J Cremers, et al.
AIDS (London, England)|September 1, 1987
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 declineJ M Lange, F de Wolf, W J Krone, et al.
Journal of Clinical Microbiology|December 17, 1998
Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivoM P de Baar, K H van der Horn, J Goudsmit, et al.
AIDS (London, England)|April 1, 1989
Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expressionP Reiss, A de Ronde, J M Lange, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 14, 2021
Evaluation of Long-term Cholesteatoma Recidivism: Using the JOS, EAONO-JOS, and STAMCO Cholesteatoma Staging SystemsMaura C Eggink, Maarten J F de Wolf, Fenna A Ebbens, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 14, 2022
Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired CholesteatomaMaura C Eggink, Maarten J F de Wolf, Fenna A Ebbens, et al.
AIDS (London, England)|January 1, 1990
Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversionV J Teeuwsen, K H Siebelink, F de Wolf, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 23, 2025
What can we learn from precise reporting of residual disease after various types of cholesteatoma surgery using STAM areas?Maura C Eggink, Maarten J F de Wolf, Fenna A Ebbens, et al.
Pageof 22

Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
Journal of Virology|January 1, 1991
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell cultureH Schuitemaker, N A Kootstra, R E de Goede, et al.
The Laryngoscope|November 9, 2018
Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatomaCatharine A Hellingman, Simon Geerse, Maarten J F de Wolf, et al.
The Laryngoscope|February 24, 2011
Better performance with bone-anchored hearing aid than acoustic devices in patients with severe air-bone gapMaarten J F de Wolf, Sander Hendrix, Cor W R J Cremers, et al.
AIDS (London, England)|September 1, 1987
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 declineJ M Lange, F de Wolf, W J Krone, et al.
Journal of Clinical Microbiology|December 17, 1998
Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivoM P de Baar, K H van der Horn, J Goudsmit, et al.
AIDS (London, England)|April 1, 1989
Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expressionP Reiss, A de Ronde, J M Lange, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 14, 2021
Evaluation of Long-term Cholesteatoma Recidivism: Using the JOS, EAONO-JOS, and STAMCO Cholesteatoma Staging SystemsMaura C Eggink, Maarten J F de Wolf, Fenna A Ebbens, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 14, 2022
Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired CholesteatomaMaura C Eggink, Maarten J F de Wolf, Fenna A Ebbens, et al.
AIDS (London, England)|January 1, 1990
Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversionV J Teeuwsen, K H Siebelink, F de Wolf, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 23, 2025
What can we learn from precise reporting of residual disease after various types of cholesteatoma surgery using STAM areas?Maura C Eggink, Maarten J F de Wolf, Fenna A Ebbens, et al.
Pageof 22